Overview

Determinants of Diabetes Remission After Gastric Bypass Surgery

Status:
Completed
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
Longitudinal study of beta cell function up to 2 years after GBP surgery. Evaluation of the role of endogenous glucagon-like peptide-1 (GLP-1).
Phase:
Early Phase 1
Details
Lead Sponsor:
Blandine Laferrere
Collaborators:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institutes of Health (NIH)